Knowledge management receptivity at a major pharmaceutical company

2000 ◽  
Vol 4 (3) ◽  
pp. 252-258 ◽  
Author(s):  
Jay Liebowitz
Keyword(s):  
Knowledge Management ◽  
Pharmaceutical Company ◽  
Major Pharmaceutical Company

PP18 An Access Evidence IT Solution Within A Pharmaceutical Company

2018 ◽  
Vol 34 (S1) ◽  
pp. 72-73
Author(s):  
Marlene Gyldmark ◽  
Rachel Rosenthal ◽  
Martin Granser ◽  
Jasmin Escher-Kirch
Keyword(s):  
Pharmaceutical Company ◽  
Market Access ◽  
Pilot Project ◽  
Core Model ◽  
Regional Market ◽  
External Stakeholders ◽  
User Friendly ◽  
Further Development ◽  
Fast Access ◽  
Major Pharmaceutical Company

Introduction:During 2014, Roche tested whether the EUnetHTA HTA Core Model© was a useful, exhaustive and relevant value framework to promote efficiencies in scoping, storing and sharing health technology assessment (HTA) evidence within a pharmaceutical company. The conclusion was positive and Roche decided to build a cloud based information technology (IT) platform to store all relevant HTA evidence to support global and regional market access activities, tagged with metadata according to the HTA Core Model©., The platform should be user-friendly and promote efficiencies and knowledge sharing across the organization. Eventually this platform may also be used by external stakeholders to access relevant HTA evidence.Methods:In order to better equip global functions, regions and affiliates in a major pharmaceutical company with user-friendly and fast access to product-relevant HTA and payer evidence as well as access evidence plans, an easy-to-use IT-based platform was needed. The platform, internally called #TAg, is a central repository of information to support market access activities and promote collaboration between Affiliate, Region and Global teams. The platform uses metadata to label all types of evidence and uses the HTA Core Model© domains to categorize the evidence.Results:The platform #TAg was developed throughout 2016/2017 and officially launched on 1 October 2017. Within the first 30 days, the platform has been readily accepted by affiliates, regions and global functions through significant use uptake as measured by user registration and download activities. In addition, #TAg was used successfully in a pilot project for a submission to an external HTA body.Conclusions:A complete knowledge management system for HTA evidence is important for driving efficiency in scoping, storing and disseminating access evidence information within a pharmaceutical company. #TAg has so far proved a good start on such a system with further development expected in the coming years.

Purinex, Inc.

2017 ◽  
pp. 1-11
Author(s):  
Robert F. Bruner ◽  
Sean Carr
Keyword(s):  
Pharmaceutical Company ◽  
The Other ◽  
Leading Compounds ◽  
Major Pharmaceutical Company

In June 2004 Purinex, Inc., a pharmaceutical company with several clinically and commercially promising drugs in development, expected to secure a partnership with a major pharmaceutical company sometime in the next four to 12 months. That partnership, if secured, would enable Purinex to develop one of its leading compounds as a drug. The company, however, had no sales or earnings and only 11 months of cash on hand. The student must assess whether the company should attempt to secure financing now or wait until it consummated a partnership deal. The tasks for the student include evaluating the probabilities that collaboration with a pharmaceutical company would actually happen; determining whether the company stay above water until such occurred; and analyzing the other risks to the company under these circumstances.

scholarly journals Technology Role in Knowledge Management - A Case Study on the Saudi Pharmaceutical Industries and Medical Appliances Company SPIMACO -: واقع التكنولوجيا الداعمة لتطبيق إدارة المعرفة في الشركات الصناعية – دراسة حالة على الشركة السعودية للصناعات الدوائية والمستلزمات الطبية "سبيماكو" أنموذجاً – السعودية -

2020 ◽  
Vol 4 (11) ◽  
Author(s):  
Dalal Ibrahim Alrebdi, Mona Dakeel Alseryhi
Keyword(s):  
Knowledge Management ◽  
Pharmaceutical Company ◽  
Business World ◽  
Entire Study ◽  
Industrial Companies ◽  
Industrial Organizations ◽  
The World ◽  
Pharmaceutical Industries ◽  
Technical Systems

The world today is living in the era of technology that has encouraged and revolutionized many fields, including the industrial fields. This revolution has led to an expansion in the business world to lead to the overwhelming use of the latest technological solutions that were discovered all around the world, which therefore has led to intense competition in the local and global markets. The need for industrial organizations to obtain accurate and timely data and information hastily contributes to decision-making and directs work more accurately and with higher quality. Therefore, we see that these industrial organizations that seek to develop, often refine systems thinking through the development of knowledge management and its application depending on its technology. From this standpoint, this study sought to shed light, examine and analyze the role of technology in the application of knowledge management, by choosing the Saudi Pharmaceutical Company, SPIMACO, as a model for industrial companies, to apply this study by polling a number of company employees، the study followed the survey approach, where the survey and interview tools were used. The entire study population consisted of (1223) employees, (320) were selected as a sample of the study.  The research reached a determination of the role of technology in the application of knowledge management in industrial companies, as it was found that the degree of availability of technical indicators supporting the application of knowledge management in this pharmaceutical company is of 'high' availability. The study also came out with a number of recommendations, the most prominent of which was the continuation of the implementation of technical systems that allow the company’s management to communicate internal knowledge, plan and execute tasks easily that helps in extracting and circulating knowledge and improving the current situation of the reality of employing the technical systems that are used in the process of measuring cognitive performance.

The Role of a Strong Corporate Mission for Knowledge Management

2011 ◽  
Vol 10 (02) ◽  
pp. 109-122 ◽  
Author(s):  
Rémy Magnier-Watanabe ◽  
Dai Senoo
Keyword(s):  
Knowledge Management ◽  
Pharmaceutical Company ◽  
Organisational Culture ◽  
Questionnaire Data ◽  
Group Time ◽  
The Impact

This research, using large questionnaire data collected from a Japanese pharmaceutical company, attempts to examine the impact of organisational culture, leadership, and reporting styles on knowledge management, which can support innovation, assessing the significance of levels of comprehension and implementation of the corporate mission. Those with a better understanding and consistent realisation of the corporate mission were found to spend significantly more time on knowledge management activities, suggesting that the organisation should better communicate the corporate mission to employees and translate it into clear objectives. Moreover, these results have revealed discriminate enablers of knowledge management among employees with higher levels of comprehension and implementation of the corporate mission and those with lower levels. In the former group, time spent on knowledge management activities was solely the result of organisational culture, while in the latter, involvement in knowledge management was the product of both high open-mindedness and more inclusive reporting. These findings suggest first that a strong mission shared and put into practice among the workforce is a powerful driver of knowledge management, and second, that open-mindedness and more inclusive reporting can substitute for a strong corporate mission and support knowledge management activities.

Development of an Orphan Drug by a Start-Up Company: MetroGel® for Rosacea

1992 ◽  
Vol 8 (4) ◽  
pp. 566-572 ◽  
Author(s):  
Robert J. Borgman
Keyword(s):  
United States ◽  
Research And Development ◽  
Pharmaceutical Company ◽  
Orphan Drug ◽  
The United States ◽  
Orphan Drug Act ◽  
Start Up ◽  
Significant Research ◽  
Marketing Costs ◽  
Major Pharmaceutical Company

AbstractThe Orphan Drug Act of 1983, along with the discovery of a new use for a known drug and an investor willing to assume the necessary risk, brought about the formation of a start-up pharmaceutical company. The primary incentive of the Orphan Drug Act of seven years of marketing exclusivity provided the protection from competition necessary for recovery of the significant research and development and marketing costs. The orphan product, MetroGel®, for the treatment of rosacea, required approximately five years of development before it was approved for marketing by the Food and Drug Administration. MetroGel® has become the number one drug in the United States for the treatment of rosacea. It currently is marketed in other countries through a licensing agreement with a major pharmaceutical company.

The knowledge loop, a knowledge management tool for academic teaching

2008 ◽  
Author(s):  
Elfriede M. Ederer-Fick ◽  
Anita Giener ◽  
Helga Kittl-Satran ◽  
Brigitte Schachner
Keyword(s):  
Knowledge Management ◽  
Management Tool ◽  
Academic Teaching
Sign in / Sign up

Export Citation Format

Share Document